Digital Self-efficacy Training to Bridge Waiting Times for Psychotherapy
1 other identifier
interventional
94
1 country
2
Brief Summary
The main aim of this project is to improve waiting periods for specialised psychotherapy. We will apply a brief, smartphone-based self-efficacy training to patients with psychiatric disorders waiting for specialised psychotherapy. Additionally, we will use Ecological Momentary Assessment (EMA) to assess mood, social contacts, and other parameters daily. We will investigate whether the training can improve self-efficacy and related constructs and if it can help reduce stress and waitlist drop-outs during waiting periods. Additionally, we will investigate if the self-efficacy training has a positive effect on motivation and therapeutical relationship regarding the subsequent therapy. After a screening for eligibility, participants will be randomly assigned to intervention and control group. At baseline, participants attend a laboratory session where they are assessed for current psychiatric disorders and further relevant psychological variables. They will then either participate in the digital self-efficacy training combined with EMA (intervention group) or in EMA only (control group). Both will be conducted via a smartphone app. Subsequently, participants will be asked to fill in post questionnaires at three different time points: after having finished app usage, one month later, and after the beginning of the subsequent psychotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2022
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 25, 2022
CompletedFirst Posted
Study publicly available on registry
September 29, 2022
CompletedStudy Start
First participant enrolled
November 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedMarch 4, 2025
November 1, 2024
3 years
September 25, 2022
February 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in self-efficacy
Validated measures ("General Self-Efficacy Scale" (10 items; higher scores indicate higher self-efficacy -\> better outcome), "Coping Self-efficacy scale" (26 items; higher scores indicate higher self-effiacy -\> better outcome) and individual questions based on validated measures assessing specific self-efficacy regarding emotion regulation, therapy and waitlist will be used to assess self-efficacy at baseline and 3 different time points after the intervention.
baseline to 1 day after the intervention, 1 month after the intervention, within 1 month after the subsequent therapy began
Secondary Outcomes (7)
Change in hopelessness
baseline to 1 day after the intervention, 1 month after the intervention, within 1 month after the subsequent therapy began
Change in anxiety
baseline to 1 day after the intervention, 1 month after the intervention, within 1 month after the subsequent therapy began
Change in stress
baseline to 1 day after the intervention, 1 month after the intervention, within 1 month after the subsequent therapy began
Change in therapy expectations
baseline to 1 day after the intervention, 1 month after the intervention, within 1 month after the subsequent therapy began
Change in depression
baseline to 1 day after the intervention, 1 month after the intervention, within 1 month after the subsequent therapy began
- +2 more secondary outcomes
Other Outcomes (3)
Change in mood and contacts
3 per day during one-week
Change in in ability to work
baseline to 1 month after the intervention, within 1 month after the subsequent therapy began
Motivation and life enjoyment
baseline to 1 day after the intervention, 1 month after the intervention, within 1 month after the subsequent therapy began
Study Arms (2)
Intervention group
EXPERIMENTALParticipants will receive an one-week digital self-efficacy training (3x/day) and an one-week Ecological Momentary Assessment (3x/day questions on mood, social and virtual contacts).
Control group
ACTIVE COMPARATORParticipants will receive an one-week Ecological Momentary Assessment (3x/day questions on mood, social and virtual contacts).
Interventions
Prior to the app participation, participants will receive psychoeducation on self-efficacy and will be instructed to define two autobiographical self-efficacy memories (own achievements, e.g., completion of an exam, success in a sporting event). During the week of app participation, they will be prompted three times per day and asked to perform an imagination task. Step by step, they will recall one of their autobiographic self-efficacy memories and focus on their character traits and abilities that were relevant for their achievement.
Participants will receive questions on mood and social/virtual contacts 3 times per day.
Eligibility Criteria
You may qualify if:
- psychiatric disorder
- age 18-65
- waiting for psychiatric assessment/treatment (being on waitlist)
- sufficient knowledge of the German language
- smartphone user
- internet access via smartphone
- internet access at home (laptop, tablet, or computer)
You may not qualify if:
- current intense psychotherapy
- acute suicidality
- acute psychotic symptoms
- substance addiction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Integrated Psychiatry Winterthur
Winterthur, Switzerland
Psychiatric University Hospital
Zurich, Switzerland
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Judith Rohde, MD
Psychiatric University Hospital Zurich, University of Zurich
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- double-blind
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinician Scientist
Study Record Dates
First Submitted
September 25, 2022
First Posted
September 29, 2022
Study Start
November 7, 2022
Primary Completion
November 1, 2025
Study Completion
November 1, 2025
Last Updated
March 4, 2025
Record last verified: 2024-11